📰 Preclinical Development News
Page 4 - Preclinical Development News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Preclinical Development. Real-time updates on events, politics, business and more.
September 27, 2023
BOSTON, Sept. 27, 2023 -- PepGen Inc. , a clinical-stage biotechnology company advancing the next generation of oligonucleotide therapies with the goal of transforming the treatment of severe...
September 14, 2023
/PRNewswire/ -- Bold Therapeutics, a clinical-stage biopharmaceutical company developing novel metallotherapeutics, is announcing its selection by Life...
September 1, 2023
BOSTON, Sept. 01, 2023 -- PepGen Inc. , a clinical-stage biotechnology company advancing the next generation of oligonucleotide therapies with the goal of transforming the treatment of severe...
September 1, 2023
BOSTON, Sept. 01, 2023 (GLOBE NEWSWIRE) -- PepGen Inc. (NASDAQ:PEPG), a clinical-stage biotechnology company advancing the next generation of oligonucleotide therapies with the goal of transforming the treatment of
August 3, 2023
Continued Enrollment in Monotherapy Dose Escalation Stage of Phase 1/2 MYCHELANGELO™ I Study; Preliminary First-in-Human Safety, Tolerability,...
August 2, 2023
Dr. Anath Shalev, renowned diabetes researcher and Chief Scientific Officer of TIXiMED, Inc., a company dedicated to the development and commercialization of TXNIP inhibiting medications, presented her work on verapamil and TXNIP inhibition at the 2023 Immunology of Diabetes Society Congress in Paris.BIRMINGHAM, Ala...
July 7, 2023
Collectively referred to as the "Transaction"). The Transaction constituted a reverse takeover of the Company by FTP under applicable securities laws. FTP became a...
June 30, 2023
Novartis has agreed to divest its front of eye ophthalmology assets to global health company Bausch + Lomb in a $2.5 billion deal, including $1.
June 27, 2023
The  Drug Discovery Outsourcing Market demand is expected to grow at a stable CAGR of 7.2% between 2023 and 2033. The market is expected to surpass a market share of US$ 7.52 billion by 2033, from a value of US$ 3.75 billion in 2023.The pharmaceutical industry’s expansion, as well as the increased penetration of dig...
June 20, 2023
Dublin, June 20, 2023 (GLOBE NEWSWIRE) -- The "Drug Discovery Outsourcing Market Size, Share & Trends Analysis Report 2023 - 2030" report has been...